0000899243-20-023658.txt : 20200831
0000899243-20-023658.hdr.sgml : 20200831
20200831095917
ACCESSION NUMBER: 0000899243-20-023658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200827
FILED AS OF DATE: 20200831
DATE AS OF CHANGE: 20200831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLARK PAUL N
CENTRAL INDEX KEY: 0001222248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 201150096
MAIL ADDRESS:
STREET 1: 5301 STEVENS CREEK BLVD
STREET 2: MS 1A-LC
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-27
0
0001098972
AGENUS INC
AGEN
0001222248
CLARK PAUL N
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to buy)
4.03
2020-08-27
4
A
0
100000
0.00
A
2030-08-27
Common Stock
100000
100000
D
Restricted Stock Unit
2020-08-27
4
A
0
11786
0.00
A
2021-08-27
Common Stock
11786
11786
D
Stock Option awarded in connection with Mr. Clark's appointment to the Board of Directors (the "Board") in accordance with the Agenus Inc. 2019 Equity Incentive Plan (the "2019 Plan") and non-employee director compensation program. Stock option vests in three equal annual installments on each of August 27, 2021, 2022 and 2023 (provided Mr. Clark maintains a service relationship with the company through each such vesting date).
Restricted Stock Unit granted in connection with Mr. Clark's appointment to the Executive Committee of the Board in accordance with the 2019 Plan. The award vests in full on August 27, 2021 (provided Mr. Clark maintains a service relationship with the company through each such vesting date).
/s/ Evan D. Kearns, as Attorney-in-Fact for Paul N. Clark
2020-08-31